Search

Bruce F Bell

Examiner (ID: 11075)

Most Active Art Unit
1741
Art Unit(s)
1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102
Total Applications
2788
Issued Applications
2338
Pending Applications
153
Abandoned Applications
297

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17603992 [patent_doc_number] => 11332463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors [patent_app_type] => utility [patent_app_number] => 17/049653 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36515 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/049653
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors Apr 28, 2019 Issued
Array ( [id] => 16786072 [patent_doc_number] => 10988484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Glucose uptake inhibitors [patent_app_type] => utility [patent_app_number] => 16/397043 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 61463 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397043 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/397043
Glucose uptake inhibitors Apr 28, 2019 Issued
Array ( [id] => 16915794 [patent_doc_number] => 20210188886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => A GOLD(III) COMPLEX, A CONJUGATE OF THE GOLD(III) COMPLEX, A PHARMACEUTICAL COMPOSITION COMPRISING THE GOLD(III) COMPLEX AND USES AND A PROCESS FOR PREPARING THE GOLD(III) COMPLEX [patent_app_type] => utility [patent_app_number] => 17/050512 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050512 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050512
Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex Apr 28, 2019 Issued
Array ( [id] => 15147609 [patent_doc_number] => 20190352282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => NOVEL MCT4 INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/395099 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395099 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/395099
MCT4 inhibitors and uses thereof Apr 24, 2019 Issued
Array ( [id] => 15405341 [patent_doc_number] => 20200022992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 16/392385 [patent_app_country] => US [patent_app_date] => 2019-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392385 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/392385
CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF Apr 22, 2019 Abandoned
Array ( [id] => 16869930 [patent_doc_number] => 20210163397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => NOVEL DICARBOXYLIC ACID DIESTERS [patent_app_type] => utility [patent_app_number] => 17/047883 [patent_app_country] => US [patent_app_date] => 2019-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047883
Dicarboxylic acid diesters Apr 22, 2019 Issued
Array ( [id] => 16711884 [patent_doc_number] => 20210079031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES [patent_app_type] => utility [patent_app_number] => 17/050263 [patent_app_country] => US [patent_app_date] => 2019-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050263 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050263
Antiviral acyclonucleoside analogues for use in treating a viral infection Apr 22, 2019 Issued
Array ( [id] => 18028900 [patent_doc_number] => 11512072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Compositions and methods for preparing and using azetidines [patent_app_type] => utility [patent_app_number] => 17/048500 [patent_app_country] => US [patent_app_date] => 2019-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10567 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048500
Compositions and methods for preparing and using azetidines Apr 18, 2019 Issued
Array ( [id] => 14929785 [patent_doc_number] => 20190300530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS [patent_app_type] => utility [patent_app_number] => 16/383382 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 524 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383382 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383382
FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS Apr 11, 2019 Abandoned
Array ( [id] => 16870000 [patent_doc_number] => 20210163467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => MORPHOLINE DERIVATES AS INHIBITORS OF VPS34 [patent_app_type] => utility [patent_app_number] => 17/046750 [patent_app_country] => US [patent_app_date] => 2019-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046750
Morpholine derivates as inhibitors of Vps34 Apr 8, 2019 Issued
Array ( [id] => 16621465 [patent_doc_number] => 20210040118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/041455 [patent_app_country] => US [patent_app_date] => 2019-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11776 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041455 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/041455
IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF Apr 2, 2019 Abandoned
Array ( [id] => 16597994 [patent_doc_number] => 20210024525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/040104 [patent_app_country] => US [patent_app_date] => 2019-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040104 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040104
Compounds for treating Huntington's disease Mar 26, 2019 Issued
Array ( [id] => 16332689 [patent_doc_number] => 20200303655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 16/761902 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 341 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761902 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/761902
Compound and organic light emitting device comprising same Mar 21, 2019 Issued
Array ( [id] => 15279995 [patent_doc_number] => 10512647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Small molecule regulators of steroid receptor coactivators and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/361600 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18605 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361600 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/361600
Small molecule regulators of steroid receptor coactivators and methods of use thereof Mar 21, 2019 Issued
Array ( [id] => 16807755 [patent_doc_number] => 20210130308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 [patent_app_type] => utility [patent_app_number] => 16/982471 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982471 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982471
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 Mar 21, 2019 Abandoned
Array ( [id] => 15468447 [patent_doc_number] => 10550086 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-04 [patent_title] => Lenvatinib derivative, and composition for pharmaceutical research and tumor therapeutic agent using the same [patent_app_type] => utility [patent_app_number] => 16/360528 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2943 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360528 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360528
Lenvatinib derivative, and composition for pharmaceutical research and tumor therapeutic agent using the same Mar 20, 2019 Issued
Array ( [id] => 14962933 [patent_doc_number] => 20190308944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => NOVEL ARYL OR HETEROARYL TRIAZOLONE DERIVATIVES OR SALTS THEREOF, OR PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 16/359984 [patent_app_country] => US [patent_app_date] => 2019-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359984 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/359984
Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same Mar 19, 2019 Issued
Array ( [id] => 16628648 [patent_doc_number] => 20210047301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 17/041883 [patent_app_country] => US [patent_app_date] => 2019-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22093 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/041883
2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same Mar 19, 2019 Issued
Array ( [id] => 14867801 [patent_doc_number] => 20190284142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => KV7 CHANNEL ACTIVATORS COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/358642 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38172 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358642 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/358642
Kv7 channel activators compositions and methods of use Mar 18, 2019 Issued
Array ( [id] => 16598023 [patent_doc_number] => 20210024554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND [patent_app_type] => utility [patent_app_number] => 16/982022 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982022 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982022
Crystalline forms and methods of producing crystalline forms of a compound Mar 17, 2019 Issued
Menu